ERIN TANNER: Open Payments
NPI 1588952774 · ALABASTER, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$77,324 in 219 payments from 21 companies in 2025. Trend: 2023 $13,729 · 2024 $33,831 · 2025 $77,324
Speaker / faculty: $58,742Travel & lodging: $12,679Food & beverage: $5,903
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 75 | $58,788 |
| Madrigal Pharmaceuticals | 22 | $9,507 |
| ABBVIE INC. | 31 | $6,913 |
| Ardelyx, Inc. | 13 | $336 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 15 | $323 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $215 |
| Janssen Scientific Affairs, LLC | 3 | $200 |
| Aimmune Therapeutics, Inc. | 9 | $152 |
| Phathom Pharmaceuticals, Inc. | 10 | $146 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $121 |
Products named: TREMFYA, REZDIFFRA, LINZESS, STELARA, IBSRELA, XIFAXAN, ENTYVIO, RINVOQ.
Industry payments across AL — which companies pay providers there.
